Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients-Reference-Cited by-同舟云学术

Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients

Published:2007-01 Issue:1 Volume:9 Page:31-38
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Schreiber S. A.,Haak T.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2006.00593.x/fullpdf

Reference20 articles.

1. Global Prevalence of Diabetes

2. DMP Diabetes mellitus: Simulationder Behandlungsergebnisse verschiedener Leitlinien

3. A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus

4. Basal insulin supplementation in type 2 diabetes

5. Issues relating to the early or earlier use of insulin in type 2 diabetes

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulintherapie bei Diabetes mellitus Typ 2: patientenzentriert, rechtzeitig, nutzen-risiko-bilanziert; Standortbestimmung 2019 nach dem ADA/EASD-Konsensus 2018;Diabetologie und Stoffwechsel;2020-01-20

2. Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study;Clinical Medicine Insights: Endocrinology and Diabetes;2020-01

3. Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world;Patient Preference and Adherence;2018-07

4. Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations;Diabetes Therapy;2017-11-01

5. Des essais randomisés contrôlés aux études observationnelles. Apports, limites et leçons. Réflexions à propos de l’étude ODYSSEE;Médecine des Maladies Métaboliques;2016-12